πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7183389

Monoclonal antibodies and cell surface antigens for the detection and treatment of small c

Molecular Discoveries, Inc. Β· Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7179888

Antigenic, non-toxic mutants of Clostridium septicum alpha toxin and vaccines, antibodies,

The Board of Regents of the University of Oklahoma Β· Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7175838

Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment

The United States of America represented by the Department of Health and Human Services Β· Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7169594

Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7163678

Reovirus for the treatment of ral-mediated cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7153866

Use of tempol for the treatment of Li-Fraumeni syndrome and ataxia telangiectasia

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7151100

Indole compounds useful for the treatment of cancer

The Regents of the University of California Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7150871

Treatment of acute lung injury, fibrosis and metastasis with antagonists of Ξ±vΞ²6

The Regents of the University of California Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7148201

Use of human plasma hyaluronidase in cancer treatment

The Regents of the University of California Β· Granted Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7141553

A3AR agonists for the treatment of inflammatory arthritis

Can-Fite Biopharma Ltd. Israel Β· Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7138237

Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen

The Regents of the University of California Β· Granted Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7135490

Method for the treatment of glomerulonephritis

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7125541

Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy

THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS Β· Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7122579

Eye treatments using synthetic thyroid hormone compositions

The Regents of the University of California Β· Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7115262

Chimeric protein for prevention and treatment of HIV infection

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7112317

Combined methods and compositions for tumor vasculature targeting and tumor treatment

The Board of Regents of the University of Texas System Β· Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105183

Chlorite in the treatment of neurodegenerative disease

The Regents of the University of California Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105561

Use of etodolac for the treatment of prostate cancer

The Regents of the University of California Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105560

Use of etodolac in the treatment of multiple myeloma

The Regents of the University of California Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105171

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamy

The Regents of the University of California Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7101557

Combined tissue factor methods for coagulation and tumor treatment

The Board of Regents of the University of Texas System Β· Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7101852

Composition and method for treatment and prevention of restenosis

The Board of Regents of the University of Texas System Β· Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7101547

Method for the prevention and treatment of diseases caused by an inflammatory response med

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7094413

Combined therapy for treatment of HIV infection

The Regents of the University of California Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted